首页> 外文期刊>Scientific reports. >IVA cloning: A single-tube universal cloning system exploiting bacterial In Vivo Assembly
【24h】

IVA cloning: A single-tube universal cloning system exploiting bacterial In Vivo Assembly

机译:IVA克隆:单管万能克隆系统利用细菌体内装配

获取原文
           

摘要

In vivo homologous recombination holds the potential for optimal molecular cloning, however, current strategies require specialised bacterial strains or laborious protocols. Here, we exploit a recA-independent recombination pathway, present in widespread laboratory E.coli strains, to develop IVA (In Vivo Assembly) cloning. This system eliminates the need for enzymatic assembly and reduces all molecular cloning procedures to a single-tube, single-step PCR, performed in 2?hours from setup to transformation. Unlike other methods, IVA is a complete system, and offers significant advantages over alternative methods for all cloning procedures (insertions, deletions, site-directed mutagenesis and sub-cloning). Significantly, IVA allows unprecedented simplification of complex cloning procedures: five simultaneous modifications of any kind, multi-fragment assembly and library construction are performed in approximately half the time of current protocols, still in a single-step fashion. This system is efficient, seamless and sequence-independent, and requires no special kits, enzymes or proprietary bacteria, which will allow its immediate adoption by the academic and industrial molecular biology community.
机译:在体内同源重组中,具有最佳分子克隆的可能性,然而,目前的策略需要专门的细菌菌株或富费治方案。这里,我们利用普遍独立的重组途径,其存在于广泛的实验室大肠杆菌菌株中,以开发IVA(体内组装)克隆。该系统消除了对酶组装的需要,并将所有分子克隆程序减少到单管的单步PCR,在从设置到转化的2小时内进行。与其他方法不同,IVA是一个完整的系统,并且对所有克隆程序的替代方法(插入,缺失,站点导向诱变和子克隆)提供了显着的优势。值得注意的是,IVA允许超出复杂克隆程序的简化:在大约一半的协议时,在大约一半的时间内进行任何种类,多碎片组件和图书馆结构的五个同时修改。该系统具有高效,无缝和序列无关,不需要特殊的套件,酶或专有细菌,这将使学术和工业分子生物学界立即采用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号